NEW YORK--(BUSINESS WIRE)--Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on developing DNA-based therapeutics for rare genetic diseases, announced today the addition of Professor Paola Leone, PhD, Director of the Cell and Gene Therapy Center, Department of Cell Biology, Rowan University, School of Osteopathic Medicine, to its Scientific Advisory Board. Dr. Leone is a leading researcher in the field of gene therapy and at the forefront of efforts focused on identifying the pathophysiologic mechanisms of neurodegenerative diseases, promoting brain repair and the preventing neurological disease progression.
“We are delighted to welcome Dr. Leone, a pioneer in gene targeting who brings a wealth of experience in the development of gene therapies for neurological diseases,” said Dr. Mark Pykett, Chief Executive Officer of Agilis. “As represented by Dr. Leone’s landmark clinical work gene therapy, her passion to bring innovative therapies to patients and her expertise with transformative approaches makes her a perfect addition to our Agilis team.”
Help employers find you! Check out all the jobs and post your resume.
